Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Bauerly, Kathryn ^a   Harris, Calliandra ^a   Chowanadisai, Winyoo ^a   Graham, James ^a   Havel, Peter J ^a   Tchaparian, Eskouhie ^b   Satre, Mike ^a   Karliner, Joel S ^c   Rucker, Robert B ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; INSULIN; LIPID; MALONALDEHYDE; PYRROLOQUINOLINEQUINONE; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY SIZE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIET RESTRICTION; DISEASE MODEL; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; INSULIN BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITIONAL STATUS; RAT; REPERFUSION INJURY; RESPIRATORY QUOTIENT; ANIMAL; BODY WEIGHT; DRUG EFFECT; HEART; HEART FUNCTION TEST; METABOLISM; MITOCHONDRION; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ANIMALIA; RATTUS;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUCOSE; HEART; HEART FUNCTION TESTS; LIPID PEROXIDATION; LIPIDS; MALONDIALDEHYDE; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NUTRITIONAL STATUS; PQQ COFACTOR; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

EID: 79960625255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021779     Document Type: Article

References (58)

1. Kumazawa T, Sato K, Seno H, Ishii A, Suzuki O, (1995) Levels of pyrroloquinoline quinone in various foods. Biochem J 307: 331-333.
2. Mitchell AE, Jones AD, Mercer RS, Rucker RB, (1999) Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem 269: 317-325.
3. Kosman VM, Stankevich NM, Makarov VG, Tikhonov VP, (2007) Biologically active substances in grated cocoa and cocoa butter. Vopr Pitan 76: 62-67.
4. Ouchi A, Nakano M, Nagaoka S, Mukai K, (2009) Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinoline quinone) in micellar solution. J Agric Food Chem 57: 450-6.
5. Hirakawa A, Shimizu K, Fukumitsu H, Furukawa S, (2009) Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun 378: 308-312.
6. Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H, (2008) Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol Pharm Bull 31: 1321-1326.
7. Misra HS, Khairnar NP, Barik A, Indira Priyadarsini K, Mohan H, et al. (2004) Pyrroloquinoline-quinone: a reactive oxygen species scavenger in bacteria. FEBS Lett 578: 26-30.
8. Miyauchi K, Urakami T, Abeta H, Shi H, Noguchi N, et al. (1999) Action of pyrroloquinolinequinol as an antioxidant against lipid peroxidation in solution. Antioxid Redox Signal 1: 547-54.
9. Hara H, Hiramatsu H, Adachi T, (2007) Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res 32: 489-95.
10. Zhu BQ, Zhou HZ, Teerlink JR, Karliner JS, (2004) Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther 18: 421-431.
11. Zhu BQ, Simonis U, Cecchini G, Zhou HZ, Li L, et al. (2006) Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 11: 119-128.
12. Liu S, Li H, Ou Yang J, Peng H, Wu K, et al. (2005) Enhanced rat sciatic nerve regeneration through silicon tubes filled with pyrroloquinoline quinone. Microsurgery 25: 329-337.
13. Tao R, Karliner JS, Simonis U, Zheng J, Zhang J, et al. (2007) Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun 363: 257-262.
14. Naito Y, Kumazawa T, Kino I, Suzuki O, (1993) Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts. Life Sci 52: 1909-1915.
15. Choi O, Kim J, Kim JG, Jeong Y, Moon JS, et al. (2008) Pyrroloquinoline quinone is a plant growth promotion factor produced by Pseudomonas fluorescens B16. Plant Physiol 146: 657-668.
16. Bauerly KA, Storms DH, Harris CB, Hajizadeh S, Sun MY, et al. (2006) Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and rat. Biochim Biophys Acta 1760: 1741-1748.
17. Steinberg FM, Gershwin ME, Rucker RB, (1994) Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr 124: 744-753.
18. Steinberg F, Stites TE, Anderson P, Storms, Chan I, et al. (2003) Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. Exp Biol Med (Maywood) 228: 160-166.
19. Tchaparian E, Marshal L, Cutler G, Bauerly K, Chowanadisai W, et al. (2010) Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways. Biochem J 429: 515-26.
20. Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, et al. (2010) Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 285: 142-152.
21. Stites T, Storms D, Bauerly K, Mah J, Harris C, et al. (2006) Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 136: 390-396.
22. Cummings BP, Digitale EK, Stanhope KL, Graham JL, Baskin DG, et al. (2008) Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat. Am J Physiol Regul Integr Comp Physiol 295: R1782-1793.
23. Holman R, (1960) The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 70: 405-410.
24. Le HD, Meisel JA, De Meijer VE, Gura KM, Puder M, (2009) The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukotrienes Essential Fatty Acids 81: 165-170.
25. Rucker R, Chowanadisai W, Nakano M, (2009) Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev 14: 268-277.
26. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, et al. (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501: 79-90.
27. Fan E, Zhang K, (2010) Targeting resveratrol to mitochondria for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 5: 97-102.
28. Page MM, Robb EL, Salway KD, Stuart JA, (2010) Mitochondrial redox metabolism: aging, longevity and dietary effects. Mech Ageing Dev 131: 242-252.
29. Hao J, Shen W, Yu G, Jia H, Li X, et al. (2010) Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem, 21: 634-44.
30. Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, et al. (2003) Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res 23: 1533-9.
31. Shen W, Hao J, Tian C, Ren J, Yang L, et al. (2008) A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS One 3: e2328.
32. Liu J, Shen W, Zhao B, Wang Y, Wertz K, et al. (2009) Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv Drug Deliv Rev 61: 1343-1352.
33. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (6): 1109-22.
34. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM, Berenguer T, Jakszyn P, et al. (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 100: 188-96.
35. De Pauw A, Tejerina S, Raes M, Keijer J, Arnold T, (2009) Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175: 927-39.
36. Erol E, Kumer LS, Cline GW, Shulman GI, Kelly DP, et al. (2004) Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J 18: 347-349.
37. Vankoningsloo S, De Pauw A, Houbion A, Tejerina S, Demazy C, et al. (2006) CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci 119: 1266-1282.
38. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-6 2007.
39. Nixon GF, (2009) Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 158: 982-993.
40. Lahiri S, Futerman AH, (2007) The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 64: 2270-2284.
41. Vessey DA, Li L, Honbo N, Karliner JS, (2009) Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol 297: H1429-1435.
42. Vessey DA, Kelley M, Li L, Huang Y, (2009) Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. Oxid Med Cell Longev 2: 146-51.
43. Yeh CC, Li H, Malhotra D, Huang MC, Zhu BQ, et al. (2009) Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. Am J Physiol Heart Circ Physiol 296: H1193-1199.
44. Jump DB, Botolin D, Wang Y, Xu J, Christian B, et al. (2005) Fatty acid regulation of hepatic gene transcription. J Nutr 135: 2503-6.
45. Nakamura MT, Cheon Y, Li Y, Nara TY, (2004) Mechanisms of regulation of gene expression by fatty acids. Lipids 39: 1077-83.
46. Jump DB, Botolin D, Wang Y, Xu J, Demeure O, et al. (2008) Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids 153: 3-13.
47. Erol E, Kumar LS, Cline GW, Shulman GI, Kelly DP, et al. (2004) Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J 18: 347-349.
48. Binas B, Erol E, (2007) FABPs as determinants of myocellular and hepatic fuel metabolism. Mol Cell Biochem 299: 75-84.
49. Montoudis A, Seidman E, Boudreau F, Beaulieu JF, Menard D, et al. (2008) Intestinal fatty acid binding protein regulates mitochondrion beta-oxidation and cholesterol uptake. J Lipid Res 49: 961-972.
50. Bass NM, (1985) Function and regulation of hepatic and intestinal fatty acid binding proteins. Chem Phys Lipids 38: 95-114.
51. Bebernitz GR, Schuster HF, (2002) The impact of fatty acid oxidation on energy utilization: targets and therapy. Curr Pharm Des 8: 1199-1227.
52. Dudley GA, Tullson PC, Terjung RL, (1987) Influence of mitochondrial content on the sensitivity of respiratory control. J Biol Chem 262: 9109-9114.
53. Terjung RL, Dudley GA, Meyer RA, (1985) Metabolic and circulatory limitations to muscular performance at the organ level. J Exp Biol 115: 307-318.
54. Geiger O, Gorisch H, (1987) Enzymatic determination of pyrroloquinoline quinone using crude membranes from Escherichia coli. Anal Biochem 164: 418-23.
55. Bergmeyer H, Berne E, (1965) Enzymatic Determination of Ketone Bodies Blood. Enzymol Biol Clin (Basel) 19: 65-76.
56. Bell GE, Stern JS, (1977) Evaluation of body composition of young obese and lean Zucker rats. Growth 41: 63-80.
57. Wong A, Cortopassi G, (2002) Reproducible quantitative PCR of mitochondrial and nuclear DNA copy number using the LightCycler. Methods Mol Biol 197: 129-137.
58. Williams RD, Wang E, Merrill AH, (1984) Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys 228: 282-2891.